EastGate Biotech Files Application to Initiate Phase III Clinical Trial for Insugin
Approximately 200 patients will be included in the Phase III study in order to achieve regulatory approval in Pakistan […]
Approximately 200 patients will be included in the Phase III study in order to achieve regulatory approval in Pakistan […]
About: NaturalShrimp, Inc. (OTCQB: SHMP) a publicly traded agro-tech company, has developed patented proprietary technology to produce fresh, gourmet-grade shrimp without the use of antibiotics, probiotics or toxic chemicals. NaturalShrimp systems are self-contained, saltwater production […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com